Investor Relations

Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve more »

OPKO Health Supports National Prostate Cancer Council Legislation more »

OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints more »

OPKO Launches the 4Kscore Test in Europe more »

Corporate Governance

The Board of Directors of OPKO Health, Inc. (the "Company") sets high standards for the Company's employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business.

Communications with the Board

Stockholders and all interested parties may initiate in writing any communication with our Board of Directors, the presiding member of the non-management directors, or any individual director by sending the correspondence to OPKO Health, Inc., 4400 Biscayne Blvd., Miami, Florida 33137, Attention: Secretary. This centralized process assists our Board of Directors in reviewing and responding to communications in an appropriate manner. If a stockholder or any interested party would like the letter to be forwarded directly to one of the Chairmen of the three standing committees of the Board, he or she should so indicate. If no specific direction is indicated, the Secretary's office will review the letter and forward it to the appropriate Board member(s).


OPKO Management and Board of Directors
» Board of Directors
» Management Team

Document View
Audit Committee Charter   PDF   39.3 KB  
Compensation Committee Charter   PDF   47.5 KB  
Governance and Nominating Committee Charter   PDF   42.4 KB  
Code of Business Conduct and Ethics HTML PDF   48.6 KB  
Corporate Governance Guidelines   PDF   28.0 KB  
Conflict Minerals Policy   PDF  158.8 KB  
Specialized Disclosure Report - Form SD   PDF   59.6 KB